Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Anticancer activity of 1, 25-(OH)<sub>2</sub>D<sub>3</sub> against human breast cancer cell lines by targeting Ras/MEK/ERK pathway</p>
Wei Zheng, Lin Cao, Linna Ouyang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 721-732
Open Access | Times Cited: 18

Showing 18 citing articles:

Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
Alberto Múñoz, William B. Grant
Nutrients (2022) Vol. 14, Iss. 7, pp. 1448-1448
Open Access | Times Cited: 173
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
Manzoor Ahmad Mir, Hina Qayoom, Umar Mehraj, et al.
Current Cancer Drug Targets (2020) Vol. 20, Iss. 8, pp. 586-602
Closed Access | Times Cited: 90
The role of vitamin D in breast cancer risk and progression
Justine Vanhevel, Lieve Verlinden, Stefanie Doms, et al.
Endocrine Related Cancer (2021) Vol. 29, Iss. 2, pp. R33-R55
Open Access | Times Cited: 59
Assessing the Antiproliferative Potential of a Novel Combretastatin A4 Derivative via Modulating Apoptosis, MAPK/ERK and PI3K/AKT Pathways in Human Breast Cancer Cells
Maiiada Nazmy, Dalia H. Abu‐Baih, Mahmoud A. Elrehany, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 8
Open Access | Times Cited: 11
Vitamin D and cancer
Ranjana P. Bird
Advances in food and nutrition research (2024), pp. 92-159
Closed Access | Times Cited: 4
Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis
Haiyan Xu, Zhenhua Liu, Hongtai Shi, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 29
1,25(OH)2 D3 induced vitamin D receptor signaling negatively regulates endoplasmic reticulum-associated degradation (ERAD) and androgen receptor signaling in human prostate cancer cells
Yalçın Erzurumlu, Esra Aydoğdu, Hatice Kübra Doğan, et al.
Cellular Signalling (2022) Vol. 103, pp. 110577-110577
Closed Access | Times Cited: 17
Vitamin D: What role in obesity-related cancer?
Pierrick Martinez, William B. Grant
Seminars in Cancer Biology (2025)
Closed Access
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
Silvia Riondino, Vincenzo Formica, Elena Valenzi, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 1220-1231
Open Access | Times Cited: 8
MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
Da Wang, Fei Xiong, Guanhua Wu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer
Wei Zheng, Peng Wei, Fuyong Qian, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 1, pp. 67-78
Closed Access | Times Cited: 1
Antiproliferative activity of Tamoxifen, Vitamin D3 and their concomitant treatment.
Derya Yetkin, Ebru Ballı, Furkan Ayaz
PubMed (2021)
Closed Access | Times Cited: 6
1,25(OH)2D3 inhibits Lewis lung cancer cell migration via NHE1‐sensitive metabolic reprograming
Hong Chen, Meizhen Zhu, Xi‐ting Wang, et al.
IUBMB Life (2023) Vol. 76, Iss. 4, pp. 182-199
Closed Access | Times Cited: 2
NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo
Ling Xiong, Liang Zhong, Lihua Yu, et al.
Cellular Signalling (2019) Vol. 65, pp. 109431-109431
Open Access | Times Cited: 5
Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases
Danyang Ren, Xin-rong Yuan, Cai‐Xia Tu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 5
ICAT mediates the inhibition of stemness and tumorigenesis in acute myeloid leukemia cells induced by 1,25-(OH)D
Yulian Wang, Lijuan Zhu, Ronghao Zeng, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 695-708
Closed Access
Vitamin D, inflammation, and cancer
Enikö Kállay, Martin Schepelmann, Laura Buburuzan
Elsevier eBooks (2023), pp. 797-824
Closed Access
Synergistic anticancer effect of combination treatment of vitamin D and pitavastatin on the HCC1937 breast cancer cells
Sanaa R. AlTawil, Mohamed Abdelrhman Adris Abdulla, Saeb Aliwaini
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1401-1409
Open Access
Page 1

Scroll to top